Recent Posts by pablo tittel

CWC Strategy

China has become a key contributor to absolute value growth in global revenues of the healthcare industry. CWC advises pharmaceutical and medical device companies on market entry strategies and broadening of market share, sourcing of manufacturing facilities and distribution platforms, support of SFDA approvals and regulatory issues, as well as facilitation of clinical trials in China. CWC has developed a broad understanding of the health care sector in China and...

Access to China

CWC Tech It is estimated that by 2020, Asia-Pacific will be the second largest market for healthcare technology. CWC offers med-tech companies aspiring to enter that Chinese market comprehensive solutions, from access strategies, expert opinion, fulfilling regulatory obligations, obtaining SFDA approvals, providing local manufacturing capabilities, creating nations-wide distribution networks, as well as governmental and private investment opportunities. Read more about CWC Tech...   CWC Invest In the past 20 years, China has begun...

Recent Comments by pablo tittel

No comments by pablo tittel yet.